Abolhassani Hassan, Farrokhi Amir Salek, Pourhamdi Shabnam, Mohammadinejad Payam, Sadeghi Bamdad, Moazzeni Seyed-Mohammad, Aghamohammadi Asghar
Research Center for Immunodeficiencies, Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.
Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Iran J Pediatr. 2013 Aug;23(4):451-7.
Common variable immunodeficiency (CVID) is a heterogeneous disorder characterized by reduced serum level of IgG, IgA or IgM and recurrent bacterial infections. Class switch recombination (CSR) as a critical process in immunoglobulin production is defective in a group of CVID patients. Activation-induced cytidine deaminase (AID) protein is an important molecule involving CSR process. The aim of this study was to investigate the AID gene mRNA production in a group of CVID patients indicating possible role of this molecule in this disorder.
Peripheral blood mononuclear cells (PBMC) of 29 CVID patients and 21 healthy controls were isolated and stimulated by CD40L and IL-4 to induce AID gene expression. After 5 days AID gene mRNA production was investigated by real time polymerase chain reaction.
AID gene was expressed in all of the studied patients. However the mean density of extracted AID mRNA showed higher level in CVID patients (230.95±103.04 ng/ml) rather than controls (210.00±44.72 ng/ml; P=0.5). CVID cases with lower level of AID had decreased total level of IgE (P=0.04) and stimulated IgE production (P=0.02); while cases with increased level of AID presented higher level of IgA (P=0.04) and numbers of B cells (P=0.02) and autoimmune disease (P=0.02).
Different levels of AID gene expression may have important roles in dysregulation of immune system and final clinical presentation in CVID patients. Therefore investigating the expression of AID gene can help in classifying CVID patients.
常见变异型免疫缺陷病(CVID)是一种异质性疾病,其特征为血清IgG、IgA或IgM水平降低以及反复发生细菌感染。类别转换重组(CSR)作为免疫球蛋白产生中的关键过程,在一组CVID患者中存在缺陷。活化诱导胞苷脱氨酶(AID)蛋白是参与CSR过程的重要分子。本研究的目的是调查一组CVID患者中AID基因mRNA的产生情况,以表明该分子在这种疾病中可能发挥的作用。
分离29例CVID患者和21例健康对照者的外周血单个核细胞(PBMC),用CD40L和IL-4刺激以诱导AID基因表达。5天后,通过实时聚合酶链反应研究AID基因mRNA的产生情况。
所有研究患者均表达AID基因。然而,提取的AID mRNA的平均密度在CVID患者中(230.95±103.04 ng/ml)高于对照组(210.00±44.72 ng/ml;P = 0.5)。AID水平较低的CVID病例总IgE水平降低(P = 0.04)且刺激后的IgE产生减少(P = 0.02);而AID水平升高的病例IgA水平较高(P = 0.04)、B细胞数量较多(P = 0.02)且自身免疫性疾病发生率较高(P = 0.02)。
AID基因表达水平的差异可能在CVID患者的免疫系统失调和最终临床表现中起重要作用。因此,研究AID基因的表达有助于对CVID患者进行分类。